Lead Author – Scientific Impact Paper: Congenital CMV

I was the lead author on the RCOG Scientific Impact Paper, Congenital Cytomegalovirus Infection: Update on Treatment (Scientific Impact Paper No. 56).

Cytomegalovirus (CMV), a member of the human herpesvirus family, is the most common viral cause of congenital infection, affecting 0.2–2.2% of all live births. It is responsible for significant morbidity, especially in infants who are symptomatic in the neonatal period. It is the leading non-genetic cause of sensorineural hearing loss (SNHL) and a major cause of neurological disability. Around 10–15% of neonates with congenital CMV will be symptomatic at birth, with a similar percentage developing problems later in childhood.

This Scientific Impact Paper summarises the issues around screening, diagnosis and treatment of CMV in pregnancy, utilising the best available evidence and highlighting recent advances.

It can be found here